Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 3/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL1145162 | 0.89 | TSHR (0.50) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL26106 | 0.89 | — | — | |
| SCHEMBL688498 | 0.89 | TSHR (0.50) | LMNADNM1TSHRTHRBOPRM1 | |
| Hexane SCHEMBL3754301 | 0.89 | TSHR (0.50) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL16969849 | 0.89 | TSHR (0.50) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL977939 | 0.89 | TSHR (0.50) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL154425 | 0.89 | TSHR (0.50) | LMNADNM1TSHRTHRBOPRM1 | |
| Hexane SCHEMBL1525236 | 0.89 | TSHR (0.50) | LMNADNM1TSHRTHRBOPRM1 | |
| Heptane SCHEMBL15226631 | 0.89 | TSHR (0.50) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL7574727 | 0.89 | TSHR (0.50) | LMNADNM1TSHRTHRBOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8669359-B2 | Electrically conducting porphyrin and porphyrin-fullerene electropolymers | ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2014-03-11 | — | — | US | disclosed |
| US-20100065123-A1 | Electrically conducting porphyrin and porphyrin-fullerene electropolymers | UNITED STATES DEPARTMENT OF ENERGY | 2010-03-18 | — | — | US | disclosed |
| WO-2008109467-A1 | ELECTRICALLY CONDUCTING PORPHYRIN AND PORPHYRIN-FULLERENE ELECTROPOLYMERS | ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2008-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100065123-A1 | Electrically conducting porphyrin and porphyrin-fullerene electropolymers | HMBS, PPOX, SLC40A1 | NAAA 3677/4885LMNA 3840/4885DNM1 753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.